Abstract:Mitochondria are heterogeneous and highly dynamic organelles, playing critical roles in adenosine triphosphate (ATP) synthesis, metabolic modulation, reactive oxygen species (ROS) generation, and cell differentiation and death. Mitochondrial dysfunction has been recognized as a contributor in many diseases. The kidney is an organ enriched in mitochondria and with high energy demand in the human body. Recent studies have been focusing on how mitochondrial dysfunction contributes to the pathogenesis of different forms of kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). AKI has been linked to an increased risk of developing CKD. AKI and CKD have a broad clinical syndrome and a substantial impact on morbidity and mortality, encompassing various etiologies and representing important challenges for global public health. Renal mitochondrial disorders are a common feature of diverse forms of AKI and CKD, which result from defects in mitochondrial structure, dynamics, and biogenesis as well as crosstalk of mitochondria with other organelles. Persistent dysregulation of mitochondrial homeostasis in AKI and CKD affects diverse cellular pathways, leading to an increase in renal microvascular loss, oxidative stress, apoptosis, and eventually renal failure. It is important to understand the cellular and molecular events that govern mitochondria functions and pathophysiology in AKI and CKD, which should facilitate the development of novel therapeutic strategies. This review provides an overview of the molecular insights of the mitochondria and the specific pathogenic mechanisms of mitochondrial dysfunction in the progression of AKI, CKD, and AKI to CKD transition. We also discuss the possible beneficial effects of mitochondrial-targeted therapeutic agents for the treatment of mitochondrial dysfunction-mediated AKI and CKD, which may translate into therapeutic options to ameliorate renal injury and delay the progression of these kidney diseases.

New Research Progresses of Mitochondria Dysfunction in Acute Kidney Injuries and Chronic Kidney Diseases

From physiology to pathology: the role of mitochondria in acute kidney injuries and chronic kidney diseases

The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential

Mitochondrial dysfunction in acute kidney injury

Mitochondrial DNA-Mediated Inflammation in Acute Kidney Injury and Chronic Kidney Disease

Mitochondrial dysfunction in the pathophysiology of renal diseases

Mitochondrial quality control in kidney injury and repair

Research Hotspots in Mitochondria-Related Studies for AKI Treatment: A Bibliometric Study

Mesenchymal Stem Cell Therapy Targeting Mitochondrial Dysfunction in Acute Kidney Injury

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury

The role of mitophagy in the development of chronic kidney disease

The multifaceted effects of mitochondria in kidney diseases

Mitochondrial Signaling, the Mechanisms of AKI-to-CKD Transition and Potential Treatment Targets

Role of mitochondria in renal ischemia–reperfusion injury

Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury

BLOOD TRANSFUSION REACTIONS : WHICH ARE LIFE-THREATENING AND WHICH ARE NOT?

Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease

Autophagy, Innate Immunity and Tissue Repair in Acute Kidney Injury

[Experimental production of maduromycotic granulations by Monosporium apiospermum and Allescheria boydii].

Role of mitochondria in pathogenesis and therapy of renal fibrosis

Mitochondria as Mediators of Systemic Inflammation and Organ Cross-talk in Acute Kidney Injury.